CoChat

Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research

Open access
Esch, Tobias, Winkler, Jeremy, Auwärter, Volker, Gnann, Heike, Huber, Roman, Schmidt, Stefan · 2017 · Frontiers in Human Neuroscience
Cited by 29

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Background: Research has demonstrated that short meditation training may yield higher pain tolerance in acute experimental pain. Our study aimed at examining underlying mechanisms of this alleged effect. In addition, placebo research has shown that higher pain tolerance is mediated via endogenous neuromodulators: experimental inhibition of opioid receptors by naloxone antagonized this effect. We performed a trial to discern possible placebo from meditation-specific effects on pain tolerance and attention. Objectives: It was proposed that (i) meditation training will increase pain tolerance; (ii) naloxone will inhibit this effect; (iii) increased pain tolerance will correlate with improved attention performance and mindfulness. Methods: Randomized-controlled, partly blinded trial with 31 healthy meditation-naïve adults. Pain tolerance was assessed by the tourniquet test, attention performance was measured by Attention Network Test (ANT), self-perceived mindfulness by Freiburg Mindfulness Inventory (FMI). 16 participants received a 5-day meditation training, focusing on body/breath awareness; the control group (N=15) received no intervention. Measures were taken before the intervention and on 3 consecutive days after the training, with all participants receiving either no infusion, naloxone infusion, or saline infusion (blinded). Blood samples were taken in order to determine serum morphine and morphine glucuronide levels by applying liquid chromatography-tandem mass spectrometry analysis. Results: The meditation group produced fewer errors in ANT. Paradoxically, increases in pain tolerance occurred in both groups (accentuated in control), and correlated with reported mindfulness. Naloxone showed a trend to decrease pain tolerance in both groups. Plasma analyses revealed sporadic morphine and/or morphine metabolite findings with no discernable pattern. Discussion: Main objectives could not be verified. Since underlying study goals had not been made explicit to participants, on purpose (framing effects towards a hypothesized mindfulness-pain tolerance correlation were thus avoided, trainees had not been instructed how to ‘use’ mindfulness, regarding pain), the question remains open whether lack of meditation effects on pain tolerance was due to these intended ‘non-placebo’ conditions, cultural effects, or other confounders, or on an unsuitable paradigm. Conclusions: Higher pain tolerance through meditation could not be confirmed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnhum.2016.00674

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Research works printed but not linked: 79

  1. Amanzio, 1999, Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems., J. Neurosci., 19, 484, 10.1523/JNEUROSCI.19-01-00484.1999 · DOI · Paper page
  2. Amanzio, 2001, Response variability to analgesics: a role for non-specific activation of endogenous opioids., Pain, 90, 205, 10.1016/S0304-3959(00)00486-3 · DOI · Paper page
  3. Banach, 2010, Morphine-mediated alteration of hypertension-related gene expression in human white blood cells and multilineage progenitor cells., J. Hum. Hypertens., 24, 713, 10.1038/jhh.2010.69 · DOI
  4. Benedetti, 1997, The neurobiology of placebo analgesia: from endogenous opioids to cholecystokinin., Prog. Neurobiol., 52, 109, 10.1016/S0301-0082(97)00006-3 · DOI · Paper page
  5. Benedetti, 1999a, Inducing placebo respiratory depressant responses in humans via opioid receptors., Eur. J. Neurosci., 11, 625, 10.1046/j.1460-9568.1999.00465.x · DOI · Paper page
  6. Benedetti, 1999b, Somatotopic activation of opioid systems by target-directed expectations of analgesia., J. Neurosci., 19, 3639, 10.1523/JNEUROSCI.19-09-03639.1999 · DOI · Paper page
  7. Benedetti, 2005, Neurobiological mechanisms of the placebo effect., J. Neurosci., 25, 10390, 10.1523/JNEUROSCI.3458-05.2005 · DOI · Paper page
  8. Benson, 1974, The relaxation response., Psychiatry, 37, 37, 10.1080/00332747.1974.11023785 · DOI · Paper page
  9. Bishop, 2004, Mindfulness: A proposed operational definition., Clin. Psychol. Sci. Pract., 11, 230, 10.1093/clipsy.bph077 · DOI · Paper page
  10. Bodnar, 2013, Endogenous opiates and behavior: 2012., Peptides, 50, 55, 10.1016/j.peptides.2013.10.001 · DOI
  11. Buchheld, 2001, Measuring mindfulness in insight meditation (vipassana) and meditation-based psychotherapy: the development of the Freiburg Mindfulness Inventory (FMI)., J. Medit. Medit. Res., 1, 11
  12. Cadet, 2007, A functionally coupled μ3-like opiate receptor/nitric oxide regulatory pathway in human multi-lineage progenitor cells., J. Immunol., 179, 5839, 10.4049/jimmunol.179.9.5839 · DOI
  13. Cadet, 2004, Endogenous morphinergic signaling and tumor growth., Front. Biosci., 9, 3176, 10.2741/1471 · DOI
  14. Casares, 2005, The American lobster, Homarus americanus, contains morphine that is coupled to nitric oxide release in its nervous and immune tissues: evidence for neurotransmitter and hormonal signaling., Neuro Endocrinol. Lett., 26, 89
  15. Chong, 2006, The mu-opioid receptor polymorphism A118G predicts cortisol responses to naloxone and stress., Neuropsychopharmacology, 31, 204, 10.1038/sj.npp.1300856 · DOI
  16. Craig, 2003, A new view of pain as a homeostatic emotion., Trends Neurosci., 26, 303, 10.1016/S0166-2236(03)00123-1 · DOI · Paper page
  17. de la Fuente-Fernández, 2006, “Placebo effect and dopamine release,” in, Parkinson’s Disease and Related Disorders, 415, 10.1007/978-3-211-45295-0_62 · DOI
  18. de la Fuente-Fernández, 2001, Expectation and dopamine release: mechanism of placebo effect in Parkinson’s disease., Science, 293, 1164, 10.1126/science.1060937 · DOI · Paper page
  19. Dusek, 2005, Association between oxygen consumption and nitric oxide production during therelaxation response., Med. Sci. Monit., 12, CR1
  20. Ernst, 2009, Die bedeutung achtsamkeitsbasierter interventionen in der medizinischen und psychotherapeutischen Versorgung., Forsch. Komplementärmed., 16, 296, 10.1159/000235795 · DOI
  21. Esch, 2014, “The neurobiology of meditation and mindfulness,” in, Meditation–Neuroscientific Approaches and Philosophical Implications, 153, 10.1007/978-3-319-01634-4_9 · DOI
  22. Esch, 2003, The therapeutic use of the relaxation response in stress-related diseases., Med. Sci. Monit., 9, RA23
  23. Esch, 2002, Stress-related diseases–a potential role for nitric oxide., Med. Sci. Monit., 8, RA103
  24. Fan, 2002, Testing the efficiency and independence of attentional networks., J. Cogn. Neurosci., 14, 340, 10.1162/089892902317361886 · DOI · Paper page
  25. Flor, 2002, Pavlovian conditioning of opioid and nonopioid pain inhibitory mechanisms in humans., Eur. J. Pain, 6, 395, 10.1016/S1090-3801(02)00043-5 · DOI · Paper page
  26. Fricchione, 2008, Identification of endogenous morphine and a mu3-like opiate alkaloid receptor in human brain tissue taken from a patient with intractable complex partial epilepsy., Med. Sci. Monit., 14, CS45
  27. Ghelardini, 2008, Molecular interaction in the mouse PAG between NMDA and opioid receptors in morphine-induced acute thermal nociception., J. Neurochem., 105, 91, 10.1111/j.1471-4159.2007.05117.x · DOI
  28. Ginzburg, 2015, Body awareness and pain habituation: the role of orientation towards somatic signals., J. Behav. Med., 38, 876, 10.1007/s10865-015-9676-8 · DOI
  29. Grevert, 1978, Endorphins: naloxone fails to alter experimental pain or mood in humans., Science, 199, 1093, 10.1126/science.343250 · DOI · Paper page
  30. Guarna, 2003, Anti-mu opioid antiserum against the third external loop of the cloned mu-opioid receptor acts as a mu receptor neutral antagonist., Mol. Brain Res., 119, 100, 10.1016/j.molbrainres.2003.08.019 · doi:10.1016/j.molbrainres.2003.08.019
  31. Hajj, 2013, Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg., Pharmacogenomics, 14, 575, 10.2217/pgs.13.13 · DOI
  32. Hayes, 2004, Mindfulness and Acceptance: Expanding the Cognitive-Behavioral Tradition.
  33. Hutchinson, 2004, In vitro opioid induced proliferation of peripheral blood immune cells correlates with in vivo cold pressor pain tolerance in humans: a biological marker of pain tolerance., Pain, 110, 751, 10.1016/j.pain.2004.05.017 · DOI
  34. Jan, 2011, L-type calcium channels and μ-opioid receptors are involved in mediating the anti-inflammatory effects of naloxone., J. Surg. Res., 167, 10.1016/j.jss.2010.03.039 · DOI
  35. Jo, 2016, Meditation and attention: a controlled study on long-term meditators in behavioral performance and event-related potentials of attentional control., Int. J. Psychophysiol., 99, 33, 10.1016/j.ijpsycho.2015.11.016 · DOI
  36. Jung, 2010, The effects of mind–body training on stress reduction, positive affect, and plasma catecholamines., Neurosci. Lett., 479, 138, 10.1016/j.neulet.2010.05.048 · DOI
  37. Kabat-Zinn, 1982, An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindulness meditation: theoretical considerations an preleminary results., Gen. Hosp. Psychiatry, 4, 33, 10.1016/0163-8343(82)90026-3 · DOI · Paper page
  38. Kemper, 2015, Loving-kindness meditation’s effects on nitric oxide and perceived well-being: a pilot study in experienced and inexperienced meditators., Explore J. Sci. Heal., 11, 32, 10.1016/j.explore.2014.10.002 · DOI
  39. Kerr, 2011, Effects of mindfulness meditation training on anticipatory alpha modulation in primary somatosensory cortex., Brain Res. Bull., 85, 96, 10.1016/j.brainresbull.2011.03.026 · DOI
  40. Kim, 2009, The effect of the μ-opioid receptor antagonist naloxone on extinction of conditioned fear in the developing rat., Learn. Mem., 16, 161, 10.1101/lm.1282309 · DOI · Paper page
  41. Kjaer, 2002, Increased dopamine tone during meditation-induced change of consciousness., Cogn. Brain Res., 13, 255, 10.1016/S0926-6410(01)00106-9 · DOI · Paper page
  42. Kream, 2007, Persistence of evolutionary memory: primordial six-transmembrane helical domain mu opiate receptors selectively linked to endogenous morphine signaling., Med. Sci. Monit., 13, SC5
  43. Kream, 2006, De novo biosynthesis of morphine in animal cells: an evidence-based model., Med. Sci. Monit., 12, RA207
  44. Kream, 2009, Endogenous morphine and nitric oxide coupled regulation of mitochondrial processes., Med. Sci. Monit., 15, RA263
  45. Kream, 2010, Interactive effects of endogenous morphine, nitric oxide, and ethanol on mitochondrial processes., Arch. Med. Sci., 6, 658, 10.5114/aoms.2010.17077 · DOI
  46. Lidstone, 2010, Effects of expectation on placebo-induced dopamine release in Parkinson disease., Arch. Gen. Psychiatry, 67, 857, 10.1001/archgenpsychiatry.2010.88 · DOI · Paper page
  47. Mantione, 2003, Effects of cold stress on morphine-induced nitric oxide production and mu-opiate receptor gene expression in Mytilus edulis pedal ganglia., Neuroendocrinol. Lett., 24, 68
  48. Mantione, 2010, Identification of a micro opiate receptor signaling mechanism in human placenta., Med. Sci. Monit., 16, BR347
  49. Mantione, 2008, Endogenous morphine signaling via nitric oxide regulates the expression of CYP2D6 and COMT: autocrine/paracrine feedback inhibition., Addict. Biol., 13, 118, 10.1111/j.1369-1600.2007.00072.x · DOI
  50. Mantione, 2007, Detection of nitric oxide in exhaled human breath: exercise and resting determinations., Med. Sci. Monit., 13, MT1
  51. Mantione, 2006, Morphine regulates gill ciliary activity via coupling to nitric oxide releasein a bivalve mollusk: opiate receptor expression in gill tissues., Med. Sci. Monit., 12, BR195
  52. Melzack, 1968, “Sensory, motivational and central control determinants of pain: a new conceptual model,” in, International Symposium on the Skin Senses, 423
  53. Miguez, 2014, Classical conditioning and pain: conditioned analgesia and hyperalgesia., Acta Psychol. (Amst.), 145, 10, 10.1016/j.actpsy.2013.10.009 · DOI
  54. Pak, 2005, Morphine via nitric oxide modulates beta-amyloid metabolism: a novel protectivemechanism for Alzheimer’s disease., Med. Sci. Monit., 11, BR357
  55. Pasternak, 2013, Mu opioids and their receptors: evolution of a concept., Pharmacol. Rev., 65, 1257, 10.1124/pr.112.007138 · DOI · Paper page
  56. Ribeiro, 2005, Interface of physical and emotional stress regulation through the endogenous opioid system and μ-opioid receptors., Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 1264, 10.1016/j.pnpbp.2005.08.011 · DOI
  57. Salamon, 2006, Pain and relaxation (review)., Int. J. Mol. Med., 18, 465
  58. Schoell, 2010, The effect of opioid receptor blockade on the neural processing of thermal stimuli., PLoS ONE, 5, 10.1371/journal.pone.0012344 · DOI · Paper page
  59. Scott, 2008, Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses., Arch. Gen. Psychiatry, 65, 220, 10.1001/archgenpsychiatry.2007.34 · DOI · Paper page
  60. Shapiro, 2006, Mechanisms of mindfulness., J. Clin. Psychol., 62, 373, 10.1002/jclp.20237 · DOI · Paper page
  61. Stefano, 2007, Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: the dopamine-morphine hypothesis., Med. Sci. Monit., 13, RA91
  62. Stefano, 2008a, The presence of endogenous morphine signaling in animals., Neurochem. Res., 33, 1933, 10.1007/s11064-008-9674-0 · DOI
  63. Stefano, 2009, Xenobiotic perturbation of endogenous morphine signaling: paradoxical opiate hyperalgesia., Med. Sci. Monit., 15, RA107
  64. Stefano, 2005, Pain, immunity, opiate and opioid compounds and health., Med. Sci. Monit., 11, MS47
  65. Stefano, 2007, Endogenous morphine synthetic pathway preceded and gave rise to catecholamine synthesis in evolution (review)., Int. J. Mol. Med., 20, 837
  66. Stefano, 2010, Dopamine, morphine, and nitric oxide: an evolutionary signaling triad., CNS Neurosci. Ther., 16, e124, 10.1111/j.1755-5949.2009.00114.x · DOI
  67. Stefano, 2008b, Endogenous morphine/nitric oxide-coupled regulation of cellular physiology and gene expression: implications for cancer biology., Semin. Cancer Biol., 18, 199, 10.1016/j.semcancer.2007.12.003 · DOI
  68. Stefano, 2012, Parkinson’s disease, L-DOPA, and endogenous morphine: a revisit., Med. Sci. Monit., 18, RA133, 10.12659/MSM.883259 · doi:10.12659/msm.883259
  69. Stefano, 2004, Morphine enhances nitric oxide release in the mammalian gastrointestinal tract via the μ3 opiate receptor subtype: a hormonal role for endogenous morphine., J. Physiol. Pharmacol., 55, 279
  70. Tsai, 2009, Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of μ-opioid receptors from Gs-protein to coupling to Gi-protein., Neuroscience, 164, 435, 10.1016/j.neuroscience.2009.08.015 · DOI
  71. Tseng, 2000, Dopamine and morphine stimulate nitric oxide release in human endometrial glandular epithelial cells., J. Soc. Gynecol. Investig., 7, 343, 10.1016/S1071-5576(00)00081-2 · doi:10.1016/s1071-5576(00)00081-2
  72. Walach, 2006, Measuring mindfulness – the Freiburg Mindfulness Inventory (FMI)., Personal. Individ. Differ., 40, 1543, 10.1017/S1352465809990361 · DOI · Paper page
  73. Welters, 2007, Morphine inhibits AP-1 activity and CD14 expression in leukocytes by a nitric oxide and opioid receptor-dependent mechanism., Eur. J. Anaesthesiol., 24, 958, 10.1017/S026502150700083X · doi:10.1017/s026502150700083x
  74. Welters, 2000, Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and μ 3 opiate receptor-dependent mechanism., J. Neuroimmunol., 111, 139, 10.1016/S0165-5728(00)00401-X · DOI
  75. Zadina, 1993, Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells., J. Pharmacol. Exp. Ther., 265, 254, 10.1016/S0022-3565(25)38093-6 · doi:10.1016/s0022-3565(25)38093-6
  76. Zhu, 2005, Human white blood cells synthesize morphine: CYP2D6 modulation., J. Immunol., 175, 7357, 10.4049/jimmunol.175.11.7357 · doi:10.4049/jimmunol.175.11.7357
  77. Zhu, 2004a, Presence of morphine in rat amygdala: evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures., Med. Sci. Monit., 10, BR433
  78. Zhu, 2004b, Opiate alkaloids and nitric oxide production in the nematode Ascaris suum., J. Parasitol., 90, 15, 10.1645/GE-3208 · doi:10.1645/ge-3208
  79. Zhu, 2009, Comparative aspects of endogenous morphine synthesis and signaling in animals., Ann. N. Y. Acad. Sci., 1163, 330, 10.1111/j.1749-6632.2008.03623.x · doi:10.1111/j.1749-6632.2008.03623.x

Cited by

See all 29

Metadata

Authors
Esch, T., Winkler, J., Auwärter, V., Gnann, H., Huber, R., & Schmidt, S.
Venue
Frontiers in Human Neuroscience
Published
2017-01-26
Volume
10
Pages
674-674
ISSN
1662-5161 (ISSN-L)
OpenAlex
W2581424408
Cited by
29
References
31
FWCI
2.53
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research. https://app.cochat.ai/papers/10.3389/fnhum.2016.00674
The paper
Esch, T., Winkler, J., Auwärter, V., Gnann, H., Huber, R., & Schmidt, S. (2017). Neurobiological Aspects of Mindfulness in Pain Autoregulation: Unexpected Results from a Randomized-Controlled Trial and Possible Implications for Meditation Research. Frontiers in Human Neuroscience. https://doi.org/10.3389/fnhum.2016.00674

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.